PUBLISHED DATE : Aug 2022 | Pages : 223
Fill out your details & get your free sample
U.S. Virtual Visits Market Size, Share, & Trends Analysis Report by
Industry Analysis Report, Regional Outlook, Market Trends, Competitive Landscape, Share, Growth Potential & Forecast, 2022 – 2027
223 Pages
53 Tables
115 Charts
1 Regions
1 Countries
37 Companies
4 Market Segment
| Report Attribute | Details |
|---|---|
| Market Size (2027) | USD 22 Billion |
| Market Size (2021) | USD 5.06 Billion |
| CAGR (2022-2027) | 27.74% |
| Base Year | 2021 |
| Forecast Year | 2022-2027 |
| Market Segments | Component, Application, Patient Group, Health Plans |
| Geographic Analysis | The U.S. |
The U.S. virtual visits market is valued at USD 5.06 billion in 2021 and is expected to grow at a CAGR of 27.74%. Virtual visits are helping make access to health care more convenient. A virtual visit is the use of technology that allows a patient to visit the physician or medical professional without having to come to a clinic or hospital and accounts for far less than the cost of a primary care office visit or an emergency room. With the increasing telehealth services utilization, there is also an increase in the adoption of virtual visit platforms. From 2017 to 2019, the virtual visit doubled for Health Action Council members.
The rising occurrences of chronic conditions such as diabetes, hypertension, and much more influence market growth. Virtual visits are useful tools for continuous monitoring of chronic conditions and treatment. Virtual visit services and technologies can help address current health issues in the US and, in turn, help deliver quality and convenient patient care. The key players in the virtual visit market are AMD Global Telemedicine, American Well, and Teladoc Health.
The U.S. is highly implementing Wi-Fi-enabled telehealth kiosks in their hospitals attributed to increasing funding for vendors offering the telehealth kiosks, which has opened prospects for growth of the virtual visits market. Telehealth kiosk is a private, standalone virtual exam room equipped with medical devices such as thermometers, pulse oximeters, blood pressure cuffs, and many more.
VIRTUAL HOSPITALS: FUTURE OF HEALTHCARE
The virtual visit has transformed the healthcare industry by reducing hospital visits, reducing patient wait time, and decreasing the physical discomfort caused to patients. Many healthcare institutions are now adopting virtual healthcare because of its many benefits. Virtual hospitals help everyone, including patients, doctors, and hospitals. Mercy Virtual Care Center, based in the US, is the prime example of a virtual hospital, the first and only facility of its kind. Key elements of a virtual hospital solution:
The market is highly dynamic and fragmented with key players, including AMD Global Telemedicine, American Well, and Teladoc Health.
Throughout the COVID-19 pandemic, people have shifted to virtual visits for medical and behavioral care because of convenience, ease of schedule, and have been found safe to avoid crowded waiting rooms. Even after post-pandemic, it is expected that about 83% of patients will use virtual care.
At the start of the pandemic, the number of in-person visits fell dramatically while virtual visits increased overall, and virtual visits have seen a drastic growth. In 2020, virtual care quickly became an integral component of care delivery due to complete lockdown and the need for healthcare, mainly mental health. The sudden growth in virtual visits adoption is observed to be due to an increase in reimbursements and ease of regulations for telehealth services. Before the COVID-19 pandemic emergence, the adoption of virtual visits remained low due to a lack of reimbursement and internet connectivity. Virtual visits increased more than 200-fold from 14,000 in 2019 to 3.1 million in 2020. In 2020, with the surge in COVID-19 cases, 53% of US patients said they were more satisfied with live video than with previous in-person interactions.
Component
The service segment is the fastest growing by component, with the highest revenue of USD 3.91 billion in 2021, whereas hardware and software have generated USD 1.15 billion. Several vendors offer a wide range of services in various specialties. The healthcare providers offer services giving both the options of a scheduled or on-demand visit. The services have widely been adopted in the country and are further expected to gain momentum in the US in the coming future.
Application
General consultation is the fastest growing segment, with the revenue generated of USD 1.47 billion in 2021, and is expected to grow at a CAGR of 26.74%. During the pandemic, the US was the most hit country, and there was a complete lockdown in the US. The fear of getting COVID-19 infection within hospitals led to increased virtual visits in the US. The behavioral health segment is expected to grow at the highest pace in the forecast period, with the highest CAGR of 28.53%, which is attributed to increasing cases of mental health issues in the US because of the increasing elderly population. Also, there are increasing initiatives to support mental health virtual visit services. Hence, it is expected that it will grow at a very good pace. Sexual and reproductive health virtual visits are the least preferred service due to inadequate insurance coverage. Many platforms are not accepting Medicaid or other public insurance for this specialty.
Patient Group
Adults are the fastest growing segment because of their increasing use of virtual visits. A rising aging population and increasing chronic diseases have increased the demand for virtual visits. The use of virtual visit platform and services is very high among the adults in the US as the country has very good IT infrastructure, good internet access, awareness, and most insurance plans covers the cost of most specialty visits. Many companies, in collaboration with virtual visit providers, cover the cost of the visit of their employees. The pediatric group is likely to grow at a good pace with a CAGR of 28.62%in the forecast period.
Health Plans
The commercial or private health plan segment generated the highest revenue of USD 2.50 billion in 2021 and is expected to grow at a very good pace with a CAGR of 28.59%. Private health insurance coverage has been more prevalent than public coverage, covering about 68.0% and 34.1% of the population in 2019. Employer-based insurance has been the most common subtype. Most Medicaid programs pay the same for telehealth-delivered services as for in-person services. As compared, online and phone visits have witnessed an 8.64% increase in the reimbursement from Medicaid for online visit reimbursement from April 2020 to December 2020. The number of people without health insurance coverage increased in 19 states in the US between 2018 and 2019. All states, including the District of Columbia, have shown a lower uninsured rate in 2019 compared to 2010. In 2019, the percentage of people with employer-provided coverage was slightly higher, from 55.2% in 2018 to 55.4% in 2019.
Frequently Asked Questions
WHAT WILL BE THE MARKET SIZE OF THE U.S. VIRTUAL VISITS MARKET?
The U.S. virtual visits market is expected to reach USD 22 billion by 2027.
WHAT IS THE GROWTH RATE IN THE U.S. VIRTUAL VISITS MARKET?
U.S. virtual visits market is expected to grow at a CAGR of 27.74% during 2022-2027.
WHO ARE THE KEY PLAYERS IN THE U.S. VIRTUAL VISITS MARKET?
AMD Global Telemedicine, American Well, Koninklijke Philips, and Teladoc Health.
WHAT ARE THE GROWTH FACTORS IN THE U.S. VIRTUAL VISITS MARKET?
Increasing funding for the virtual visits platforms, the emergence of new business models in healthcare, and rising reimbursements by insurers & governments for virtual visits are the major growth factors in the market.
WHAT ARE THE LATEST TRENDS IN THE U.S. VIRTUAL VISITS MARKET?
Increasing virtual visits in the pediatric population, the introduction of automated virtual primary care, and emerging connected/smart integrated devices
U.S. virtual visits market was valued at USD 5.06 billion in 2021 and is expected to reach USD 22 billion by 2027, growing at a CAGR of 27.74% during 2022-2027
The following factors are likely to contribute to the growth of the U.S. virtual visits market during the forecast period:
Base Year: 2021
Forecast Year: 2022–2027
The study considers the present scenario of the U.S. virtual visits market and its market dynamics for 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.
Key Vendors
Other Prominent Vendors
Market Segmentation by Component
Market Segmentation by Application
Market Segmentation by Patient Group
Market Segmentation by Health Plans
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY COMPONENT
4.3.2 MARKET SEGMENTATION BY APPLICATION
4.3.3 MARKET SEGMENTATION BY PATIENT GROUP
4.3.4 MARKET SEGMENTATION BY HEALTH PLANS
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 OVERVIEW
7.1.1 RISE IN ADOPTION OF ADVANCED PATIENT CARE PLATFORMS
8 PREMIUM INSIGHTS
8.1 OVERVIEW
8.1.1 VIRTUAL HOSPITALS: FUTURE OF HEALTHCARE
8.1.2 VENDOR ACTIVITIES IN THE MARKET
8.1.3 IMPACT OF COVID-19 PANDEMIC
8.1.4 SEGMENTATION INSIGHTS
8.2 VIRTUAL VISITS STATUS IN US BETWEEN 2019 AND 2021 & BEYOND
8.2.1 FUTURE IN VIRTUAL VISITS SERVICES
8.3 DECLINING TELEHEALTH ADOPTION RATE OF LATE COVID-19 PANDEMIC VISITS
8.4 SNAPSHOT OF TELEHEALTH IN US
8.4.1 AGE GROUPS: SHARE OF OUTPATIENTS BY TELEHEALTH
8.5 REIMBURSEMENTS FOR VIRTUAL VISITS/CARE IN RESPONSE TO COVID-19 PANDEMIC
9 MARKET OPPORTUNITIES & TRENDS
9.1 USE OF VIRTUAL VISIT CONSULTATIONS IN PEDIATRIC TREATMENT
9.2 INTRODUCTION OF AUTOMATED VIRTUAL PRIMARY CARE
9.3 INCREASING USE OF TELEHEALTH KIOSKS
9.4 EMERGING CONNECTED/SMART INTEGRATED DEVICES
9.5 INCREASING STRATEGIC PARTNERSHIPS AND MERGERS/ACQUISITIONS
10 MARKET GROWTH ENABLERS
10.1 INCREASING FUNDING TOWARD VIRTUAL VISITS PLATFORMS
10.2 EMERGENCE OF NEW BUSINESS MODELS IN HEALTHCARE
10.3 INCREASING REIMBURSEMENTS BY INSURERS AND GOVERNMENTS FOR VIRTUAL VISITS
10.4 CHRONIC DISEASE MANAGEMENT THROUGH VIRTUAL VISITS
11 MARKET RESTRAINTS
11.1 LACK OF ACCESS TO FIXED INTERNET SERVICE
11.2 DATA SECURITY AND PRIVACY RISKS
11.3 LEGAL BARRIERS & LACK OF STANDARD REGULATIONS
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.1.1 US MARKET SNAPSHOT
12.2 MARKET SIZE & FORECAST
12.2.1 COMPONENT
12.2.2 APPLICATION
12.2.3 PATIENT GROUP
12.2.4 HEALTH PLANS
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY
13 COMPONENT
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 SERVICE
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.4 HARDWARE & SOFTWARE
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
14 APPLICATION
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 GENERAL CONSULTATION
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.4 BEHAVIORAL HEALTH
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.5 CHRONIC CARE MANAGEMENT
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.6 URGENT CARE
14.6.1 MARKET OVERVIEW
14.6.2 MARKET SIZE & FORECAST
14.7 OTHERS
14.7.1 MARKET OVERVIEW
14.7.2 MARKET SIZE & FORECAST
15 PATIENT GROUP
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 ADULTS
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.4 PEDIATRIC
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
16 HEALTH PLANS
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 MARKET OVERVIEW
16.3 COMMERCIAL
16.3.1 MARKET OVERVIEW
16.3.2 MARKET SIZE & FORECAST
16.4 MEDICARE
16.4.1 MARKET OVERVIEW
16.4.2 MARKET SIZE & FORECAST
16.5 SELF-PAY
16.5.1 MARKET OVERVIEW
16.5.2 MARKET SIZE & FORECAST
16.6 OTHERS
16.6.1 MARKET OVERVIEW
16.6.2 MARKET SIZE & FORECAST
17 COMPETITIVE LANDSCAPE
17.1 COMPETITION OVERVIEW
17.2 MARKET SHARE ANALYSIS
17.2.1 AMD GLOBAL TELEMEDICINE
17.2.2 AMERICAN WELL
17.2.3 KONINKLIJKE PHILIPS
17.2.4 TELADOC HEALTH
18 KEY COMPANY PROFILES
18.1 AMD GLOBAL TELEMEDICINE
18.1.1 BUSINESS OVERVIEW
18.1.2 PRODUCT OFFERINGS
18.1.3 KEY STRATEGIES
18.1.4 KEY STRENGTHS
18.1.5 KEY OPPORTUNITIES
18.2 AMERICAN WELL
18.2.1 BUSINESS OVERVIEW
18.2.2 PRODUCT OFFERINGS
18.2.3 KEY STRATEGIES
18.2.4 KEY STRENGTHS
18.2.5 KEY OPPORTUNITIES
18.3 KONINKLIJKE PHILIPS
18.3.1 BUSINESS OVERVIEW
18.3.2 PRODUCT OFFERINGS
18.3.3 KEY STRATEGIES
18.3.4 KEY STRENGTHS
18.3.5 KEY OPPORTUNITIES
18.4 TELADOC HEALTH
18.4.1 BUSINESS OVERVIEW
18.4.2 PRODUCT OFFERINGS
18.4.3 KEY STRATEGIES
18.4.4 KEY STRENGTHS
18.4.5 KEY OPPORTUNITIES
19 OTHER PROMINENT VENDORS
19.1 BANNER HEALTH
19.1.1 BUSINESS OVERVIEW
19.1.2 PRODUCT OFFERINGS
19.2 BETTERHELP
19.2.1 BUSINESS OVERVIEW
19.2.2 PRODUCT OFFERINGS
19.3 BLUE SKY TELEHEALTH
19.3.1 BUSINESS OVERVIEW
19.3.2 PRODUCT OFFERINGS
19.4 CARECLIX
19.4.1 BUSINESS OVERVIEW
19.4.2 PRODUCT OFFERINGS
19.5 CERNER
19.5.1 BUSINESS OVERVIEW
19.5.2 PRODUCT OFFERINGS
19.6 CHI HEALTH
19.6.1 BUSINESS OVERVIEW
19.6.2 PRODUCT OFFERINGS
19.7 CHIRON HEALTH
19.7.1 BUSINESS OVERVIEW
19.7.2 PRODUCT OFFERINGS
19.8 CISCO SYSTEMS
19.8.1 BUSINESS OVERVIEW
19.8.2 PRODUCT OFFERINGS
19.9 CVS HEALTH
19.9.1 BUSINESS OVERVIEW
19.9.2 PRODUCT OFFERINGS
19.10 DOCTOR ON DEMAND
19.10.1 BUSINESS OVERVIEW
19.10.2 PRODUCT OFFERINGS
19.11 DOXY.ME
19.11.1 BUSINESS OVERVIEW
19.11.2 PRODUCT OFFERINGS
19.12 EAGLE TELEMEDICINE
19.12.1 BUSINESS OVERVIEW
19.12.2 PRODUCT OFFERINGS
19.13 EDGEMED HEALTHCARE
19.13.1 BUSINESS OVERVIEW
19.13.2 PRODUCT OFFERINGS
19.14 EVISIT
19.14.1 BUSINESS OVERVIEW
19.14.2 PRODUCT OFFERINGS
19.15 HEALTHTAP
19.15.1 BUSINESS OVERVIEW
19.15.2 PRODUCT OFFERINGS
19.16 K HEALTH
19.16.1 BUSINESS OVERVIEW
19.16.2 PRODUCT OFFERINGS
19.17 MASIMO
19.17.1 BUSINESS OVERVIEW
19.17.2 PRODUCT OFFERINGS
19.18 MDLIVE
19.18.1 BUSINESS OVERVIEW
19.18.2 PRODUCT OFFERINGS
19.19 NEXTCARE
19.19.1 BUSINESS OVERVIEW
19.19.2 PRODUCT OFFERINGS
19.20 NURX
19.20.1 BUSINESS OVERVIEW
19.20.2 PRODUCT OFFERINGS
19.21 PLUSHCARE
19.21.1 BUSINESS OVERVIEW
19.21.2 PRODUCT OFFERINGS
19.22 PIEDMONT HEALTHCARE
19.22.1 BUSINESS OVERVIEW
19.22.2 PRODUCT OFFERINGS
19.23 RECURO HEALTH
19.23.1 BUSINESS OVERVIEW
19.23.2 PRODUCT OFFERINGS
19.24 RO
19.24.1 BUSINESS OVERVIEW
19.24.2 PRODUCT OFFERINGS
19.25 SOC TELEMED
19.25.1 BUSINESS OVERVIEW
19.25.2 PRODUCT OFFERINGS
19.26 STEADYMD
19.26.1 BUSINESS OVERVIEW
19.26.2 PRODUCT OFFERINGS
19.27 TALKSPACE
19.27.1 BUSINESS OVERVIEW
19.27.2 PRODUCT OFFERINGS
19.28 OPTUM
19.28.1 BUSINESS OVERVIEW
19.28.2 PRODUCT OFFERINGS
19.29 VIDYO
19.29.1 BUSINESS OVERVIEW
19.29.2 PRODUCT OFFERINGS
19.30 VSEE
19.30.1 BUSINESS OVERVIEW
19.30.2 PRODUCT OFFERINGS
19.31 WALMART HEALTH VIRTUAL CARE
19.31.1 BUSINESS OVERVIEW
19.31.2 PRODUCT OFFERINGS
19.32 ZIPNOSIS
19.32.1 BUSINESS OVERVIEW
19.32.2 PRODUCT OFFERINGS
19.33 98POINT6
19.33.1 BUSINESS OVERVIEW
19.33.2 PRODUCT OFFERINGS
20 REPORT SUMMARY
20.1 KEY TAKEAWAYS
20.2 STRATEGIC RECOMMENDATIONS
21 QUANTITATIVE SUMMARY
21.1 COMPONENT
21.2 APPLICATION
21.3 PATIENT GROUP
21.4 HEALTH PLANS
22 APPENDIX
22.1 ABBREVIATIONS
LIST OF EXHIBITS
EXHIBIT 1 US VIRTUAL VISITS MARKET: SEGMENTATION
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
EXHIBIT 3 SUMMARY OF MEDICARE VIRTUAL VISIT SERVICES
EXHIBIT 4 VIRTUAL VISITS DURING 2017-2019 IN VARIOUS SPECIALTIES
EXHIBIT 5 US ADULTS OWNING OR USING TECHNOLOGY 2018K (% SHARE)
EXHIBIT 6 RISE IN PATIENT-CARE TECHNOLOGY
EXHIBIT 7 MARKET SHARE BASED ON SEGMENTS - 2021
EXHIBIT 8 VIRTUAL VISITS IN US MARKET: SNAPSHOT
EXHIBIT 9 MAJOR FACTORS FOR DECLINING VIRTUAL VISITS SERVICES POST-PANDEMIC 2022
EXHIBIT 10 TELEHEALTH REIMBURSEMENT CLAIMS TREND BETWEEN JANUARY 2020 & JANUARY 2022
EXHIBIT 11 INCREASE IN HYBRID PREFERENCE (IN-PERSON & TELEHEALTH VISITS) 2021
EXHIBIT 12 SHARE OF OUTPATIENT VISITS BY TELEHEALTH 2019-2021
EXHIBIT 13 AGE GROUPS SHARE OF OUTPATIENT VISITS BY TELEHEALTH
EXHIBIT 14 SHARE OF OUTPATIENT VISITS BY TELEHEALTH BY AREA TYPE
EXHIBIT 15 SHARE OF OUTPATIENT VISITS BY TELEHEALTH BY GENDER TYPE
EXHIBIT 16 SHARE OF OUTPATIENT VISITS BY TELEHEALTH FOR SELECTED CHRONIC CONDITIONS 2020-2021
EXHIBIT 17 IMPACT OF USE OF VIRTUAL VISIT CONSULTATIONS IN PEDIATRIC TREATMENT
EXHIBIT 18 PARENTS INDICATING PREFERENCE FOR TYPE OF VISIT FOR THEIR CHILDREN 2021
EXHIBIT 19 PEDIATRIC VIRTUAL VISITS BY SPECIALTY IN NORTH AMERICA
EXHIBIT 20 AMBULATORY VIRTUAL VISITS AMONG PEDIATRIC POPULATION BEFORE COVID-19 & DURING COVID-19 IN US
EXHIBIT 21 IMPACT OF INTRODUCTION OF AUTOMATED VIRTUAL PRIMARY CARE
EXHIBIT 22 AUTOMATED VIRTUAL CARE
EXHIBIT 23 IMPACT OF INCREASING USE OF TELEHEALTH KIOSKS
EXHIBIT 24 IMPACT OF EMERGING CONNECTED/SMART INTEGRATED DEVICES
EXHIBIT 25 IMPACT OF INCREASING STRATEGIC PARTNERSHIPS & MERGERS/ACQUISITIONS
EXHIBIT 26 IMPACT OF INCREASING FUNDING TOWARD VIRTUAL VISITS PLATFORMS
EXHIBIT 27 TOTAL VENTURE FUNDING FOR DIGITAL HEALTH COMPANIES 2017-2020 ($ BILLION)
EXHIBIT 28 TOP INITIATIVES TO OPTIMIZE ADOPTION OF VIRTUAL HEALTH
EXHIBIT 29 IMPACT OF EMERGENCE OF NEW BUSINESS MODELS IN HEALTHCARE
EXHIBIT 30 PERCENTAGE SHIFT OF SERVICES TO VIRTUAL VISITS BY 2040
EXHIBIT 31 IMPACT OF INCREASING REIMBURSEMENTS BY INSURERS AND GOVERNMENTS FOR VIRTUAL VISITS
EXHIBIT 32 IMPACT OF CHRONIC DISEASE MANAGEMENT THROUGH VIRTUAL VISITS
EXHIBIT 33 BENEFITS OF VIRTUAL VISITS FOR BETTER CHRONIC DISEASE MANAGEMENT
EXHIBIT 34 IMPACT OF LACK OF ACCESS TO FIXED INTERNET SERVICE
EXHIBIT 35 IMPACT OF DATA SECURITY AND PRIVACY RISKS
EXHIBIT 36 PERCENTAGE OF E US PEOPLE WHO FEEL CONTROL OVER WHO CAN ACCESS THE FOLLOWING TYPES OF THEIR INFORMATION (2019)
EXHIBIT 37 IMPACT OF LEGAL BARRIERS & LACK OF STANDARD REGULATIONS
EXHIBIT 38 ADVANTAGES OF PRACTICING MEDICINE VIRTUALLY
EXHIBIT 39 RESPONDENTS WHO AGREE WITH THE FOLLOWING SERVICES TO CONTINUE ONCE COVID-19 CRISIS ABATES
EXHIBIT 40 TELEHEALTH AMBULATORY CONTACT TYPES FOR CONTINUOUSLY ENROLLED INSURED STUDY COHORT FROM MARCH TO JUNE 2020
EXHIBIT 41 NUMBER OF VIRTUAL VISITS 2019-2020
EXHIBIT 42 NUMBER OF HEATH CENTERS OFFERING VIRTUAL VISITS (2019 AND 2022)
EXHIBIT 43 NARROWING OF INTERNET GAP IN US
EXHIBIT 44 LAPSED USERS OF TELEHEALTH SERVICES FOR GIVEN REASONS IN US, 2020 (% SHARE)
EXHIBIT 45 US VIRTUAL VISITS MARKET 2021–2027 ($ BILLION)
EXHIBIT 46 US VIRTUAL VISITS MARKET BY COMPONENT 2021 & 2027 (%)
EXHIBIT 47 US VIRTUAL VISITS MARKET BY APPLICATION 2021 & 2027 (%)
EXHIBIT 48 US VIRTUAL VISITS MARKET BY PATIENT GROUP 2021 & 2027 (%)
EXHIBIT 49 US VIRTUAL VISITS MARKET BY HEALTH PLANS 2021 & 2027 (%)
EXHIBIT 50 FIVE FORCES ANALYSIS 2021
EXHIBIT 51 INCREMENTAL GROWTH BY COMPONENT 2021 & 2027
EXHIBIT 52 US VIRTUAL VISITS MARKET BY COMPONENT
EXHIBIT 53 US VIRTUAL VISITS MARKET BY COMPONENT – MARKET OVERVIEW
EXHIBIT 54 US VIRTUAL VISITS MARKET BY SERVICE – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 55 US VIRTUAL VISITS MARKET BY SERVICE 2021–2027 ($ BILLION)
EXHIBIT 56 US VIRTUAL VISITS MARKET BY HARDWARE & SOFTWARE – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 57 US VIRTUAL VISITS MARKET BY HARDWARE & SOFTWARE 2021–2027 ($ BILLION)
EXHIBIT 58 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 59 US VIRTUAL VISITS MARKET BY APPLICATION
EXHIBIT 60 US VIRTUAL VISITS MARKET BY APPLICATION – MARKET OVERVIEW
EXHIBIT 61 TELEMEDICINE VISITS ACROSS SPECIALTIES FROM 2018-2020 IN US
EXHIBIT 62 TELEHEALTH CLAIMS IN US SEPTEMBER 2019 (% SHARE)
EXHIBIT 63 TELEHEALTH CLAIMS IN US SEPTEMBER 2020 (% SHARE)
EXHIBIT 64 SHORT-TERM, LONG-TERM, AND PREVENTIVE CARE VIRTUAL VISITS ACROSS SPECIALTIES IN US FROM 2018-2020 (%)
EXHIBIT 65 US VIRTUAL VISITS MARKET BY GENERAL CONSULTATION – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 66 US VIRTUAL VISITS MARKET BY GENERAL CONSULTATION 2021–2027 ($ BILLION)
EXHIBIT 67 US VIRTUAL VISITS MARKET BY BEHAVIORAL HEALTH 2021–2027 ($ BILLION)
EXHIBIT 68 US VIRTUAL VISITS MARKET BY BEHAVIORAL HEALTH – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 69 RISK FACTORS FOR CHRONIC DISEASES
EXHIBIT 70 US VIRTUAL VISITS MARKET BY CHRONIC CARE MANAGEMENT – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 71 US VIRTUAL VISITS MARKET BY CHRONIC CARE MANAGEMENT 2021–2027 ($ BILLION)
EXHIBIT 72 US VIRTUAL VISITS MARKET BY URGENT CARE – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 73 US VIRTUAL VISITS MARKET BY URGENT CARE 2021–2027 ($ BILLION)
EXHIBIT 74 MOST COMMON SKIN DISEASES FOUND IN A STUDY OF 2,701 INDIVIDUALS IN 2019 (%)
EXHIBIT 75 US VIRTUAL VISITS MARKET BY OTHERS 2021–2027 ($ BILLION)
EXHIBIT 76 US VIRTUAL VISITS MARKET BY OTHERS – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 77 INCREMENTAL GROWTH BY PATIENT GROUP 2021 & 2027
EXHIBIT 78 US VIRTUAL VISITS MARKET BY PATIENT GROUP
EXHIBIT 79 US VIRTUAL VISITS MARKET BY PATIENT GROUP – MARKET OVERVIEW
EXHIBIT 80 TELEHEALTH VISITS BY AGE-GROUP DECEMBER 2020 (% SHARE)
EXHIBIT 81 US VIRTUAL VISITS MARKET BY ADULTS– INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 82 PERCENTAGE OF ADULTS (50-80 YEARS) VISITED VIRTUAL VISITS BY SERVICE 2020
EXHIBIT 83 US VIRTUAL VISITS MARKET 2021–2027 BY ADULTS ($ BILLION)
EXHIBIT 84 US VIRTUAL VISITS MARKET BY PEDIATRIC– INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 85 PEDIATRIC PATIENTS SEEN BY VIDEO VISIT IN 2020
EXHIBIT 86 US VIRTUAL VISIT MARKET BY PEDIATRICS 2021–2027 ($ BILLION)
EXHIBIT 87 INCREMENTAL GROWTH BY HEALTH PLANS 2021 & 2027
EXHIBIT 88 US VIRTUAL VISITS MARKET BY HEALTH PLANS
EXHIBIT 89 US VIRTUAL VISITS MARKET BY HEALTH PLANS– MARKET OVERVIEW
EXHIBIT 90 AMBULATORY VISITS BY PAYER TYPE
EXHIBIT 91 VIRTUAL VISIT DELIVERY BY PAYER
EXHIBIT 92 TOP COMMERCIAL TELEHEALTH INSURANCE COMPANIES WITH HIGHEST NUMBER OF MEMBERS (2019)
EXHIBIT 93 US VIRTUAL VISITS MARKET BY COMMERCIAL 2021–2027 ($ BILLION)
EXHIBIT 94 US VIRTUAL VISITS MARKET BY COMMERCIAL – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 95 ROADMAP TO PARTS OF MEDICARE
EXHIBIT 96 US VIRTUAL VISIT MARKET BY MEDICARE 2021–2027 ($ BILLION)
EXHIBIT 97 US VIRTUAL VISITS MARKET BY MEDICARE – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 98 OUT-OF-POCKET COSTS FROM PROVIDERS
EXHIBIT 99 COSTS OF VISITS WITH INSURANCE
EXHIBIT 100 US VIRTUAL VISIT MARKET BY SELF-PAY 2021–2027 ($ BILLION)
EXHIBIT 101 US VIRTUAL VISITS MARKET BY SELF-PAY – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 102 FIRMS WITH PLANS OF HIGH TELEMEDICINE ENROLLMENT COVERS BY FIRM SIZE 2015-2021
EXHIBIT 103 US VIRTUAL VISIT MARKET BY OTHERS 2021–2027 ($ BILLION)
EXHIBIT 104 US VIRTUAL VISITS MARKET BY OTHERS – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 105 PURE &DIVERSIFIED VENDORS OFFERING VIRTUAL VISITS IN THE US
EXHIBIT 106 VENDORS OFFERING VIRTUAL VISITS: MARKET DOMINANCE ANALYSIS
EXHIBIT 107 VENDORS OFFERING VIRTUAL CARE VISITS: CAPABILITIES & EXPERTISE ASSESSMENT
EXHIBIT 108 AMERICAN WELL: TOTAL REVENUE 2019-2021 ($ MILLION)
EXHIBIT 109 AMERICAN WELL: TOTAL RESEARCH AND DEVELOPMENT EXPENDITURE 2029-2021 ($ MILLION)
EXHIBIT 110 AMERICAN WELL: TOTAL PLATFORM SUBSCRIPTION REVENUE 2029-2021 ($ MILLION)
EXHIBIT 111 AMERICAN WELL: TOTAL VISITS REVENUE 2029-2021 ($ MILLION)
EXHIBIT 112 KONINKLIJKE PHILIPS: TOTAL REVENUE 2029-2021 ($ MILLION)
EXHIBIT 113 KONINKLIJKE PHILIPS: MARKET SHARE BY REPORTABLE SEGMENTS- 2021 (%)
EXHIBIT 114 TELADOC HEALTH: TOTAL REVENUE 2019-2021 ($ MILLION)
EXHIBIT 115 TELADOC HEALTH: US TOTAL REVENUE 2019-2021 ($ MILLION)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015−2021
TABLE 3 HEALTH INSURANCE PROVIDERS RESPONSE TO COVID-19
TABLE 4 NUMBER OF CONNECTIVE SMART DEVICES OFFERED BY AMERICAN WELL
TABLE 5 NUMBER OF INTEGRATED SMART DEVICES OFFERED BY AMERICAN WELL
TABLE 6 RECENT MERGERS/ACQUISITIONS IN VIRTUAL VISITS -US
TABLE 7 CAPITAL RAISE BY T US COMPANIES VIRTUAL VISITS IN 2021
TABLE 8 HOME INTERNET CONNECTION TYPES IN US
TABLE 9 AMD GLOBAL TELEMEDICINE: MAJOR PRODUCT OFFERINGS
TABLE 10 AMERICAN WELL: MAJOR SERVICE/PRODUCT OFFERINGS
TABLE 11 KONINKLIJKE PHILIPS: MAJOR PRODUCT OFFERINGS
TABLE 12 TELADOC HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 13 BANNER HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 14 BETTERHELP: PRODUCT OFFERINGS
TABLE 15 BLUE SKY TELEHEALTH: MAJOR SERVICE OFFERINGS
TABLE 16 CARECLIX: MAJOR PRODUCT OFFERINGS
TABLE 17 CERNER: MAJOR PRODUCT OFFERINGS
TABLE 18 CHI HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 19 CHIRON HEALTH: PRODUCT OFFERINGS
TABLE 20 CISCO SYSTEMS: MAJOR PRODUCT OFFERINGS
TABLE 21 CVS HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 22 DOCTOR ON DEMAND: MAJOR PRODUCT OFFERINGS
TABLE 23 DOXY.ME: PRODUCT OFFERINGS
TABLE 24 EAGLE TELEMEDICINE: MAJOR PRODUCT OFFERINGS
TABLE 25 EDGEMED HEALTHCARE: PRODUCT OFFERINGS
TABLE 26 EVISIT: MAJOR PRODUCT OFFERINGS
TABLE 27 HEALTHTAP: MAJOR PRODUCT OFFERINGS
TABLE 28 K HEALTH: PRODUCT OFFERINGS
TABLE 29 MASIMO: PRODUCT OFFERINGS
TABLE 30 MDLIVE: MAJOR PRODUCT OFFERINGS
TABLE 31 NEXTCARE: PRODUCT OFFERINGS
TABLE 32 NURX: PRODUCT OFFERINGS
TABLE 33 PLUSHCARE: PRODUCT OFFERINGS
TABLE 34 PIEDMONT HEALTHCARE: PRODUCT OFFERINGS
TABLE 35 RECURO HEALTH: PRODUCT OFFERINGS
TABLE 36 RO: PRODUCT OFFERINGS
TABLE 37 SOC TELEMED: MAJOR PRODUCT OFFERINGS
TABLE 38 STEADYMD: MAJOR PRODUCT OFFERINGS
TABLE 39 TALKSPACE: PRODUCT OFFERINGS
TABLE 40 OPTUM: MAJOR PRODUCT OFFERINGS
TABLE 41 VIDYO: MAJOR PRODUCT OFFERINGS
TABLE 42 VSEE: PRODUCT OFFERINGS
TABLE 43 WALMART HEALTH VIRTUAL CARE: MAJOR PRODUCT OFFERINGS
TABLE 44 ZIPNOSIS: PRODUCT OFFERINGS
TABLE 45 98POINT6: PRODUCT OFFERINGS
TABLE 46 US VIRTUAL VISITS MARKET BY COMPONENT 2021−2027 ($ BILLION)
TABLE 47 US VIRTUAL VISITS MARKET BY COMPONENT 2021−2027 (%)
TABLE 48 US VIRTUAL VISITS MARKET BY APPLICATION 2021−2027 ($ BILLION)
TABLE 49 US VIRTUAL VISITS MARKET BY APPLICATION 2021−2027 (%)
TABLE 50 US VIRTUAL VISITS MARKET BY PATIENT GROUP 2021−2027 ($ BILLION)
TABLE 51 US VIRTUAL VISITS MARKET BY PATIENT GROUP 2021−2027 (%)
TABLE 52 US VIRTUAL VISITS MARKET BY HEALTH PLANS 2021−2027 ($ BILLION)
TABLE 53 US VIRTUAL VISITS MARKET BY HEALTH PLANS 2021−2027 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
